Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability
of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost
of accommodating, announced increases in the build rates
of certain aircraft; 6) the effect on aircraft demand and build rates
of changing customer preferences for business aircraft, including the effect
of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result
of global economic uncertainty or otherwise; 8) the effect
of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution
of key milestones such as the receipt
of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation
of our announced acquisition
of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability
of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk
of nonpayment by such customers; 13) any
adverse impact on Boeing's and Airbus» production
of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts
of terrorism; 14) any
adverse impact on the demand for air travel or our operations from the outbreak
of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact
of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition
of Asco on favorable terms or
at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect
of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect
of changes in tax law, such as the effect
of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations
of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect
of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability
of raw materials and purchased components; 23) our ability to recruit and retain a critical mass
of highly - skilled employees and our relationships with the unions representing many
of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment
of interest on, and principal
of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness
of any interest rate hedging programs; 28) the effectiveness
of our internal control over financial reporting; 29) the
outcome or impact
of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition
of Asco in a timely matter while avoiding any unexpected costs, charges, expenses,
adverse changes to business relationships and other business disruptions for ourselves and Asco as a result
of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks
of doing business internationally, including fluctuations in foreign current exchange rates, impositions
of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
These risks and uncertainties include, among others: the unfavorable
outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any
of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components
of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence
of efficacy and adequacy
of bridging to buprenorphine; clinical development activities may not be completed on time or
at all; the results
of our clinical development activities may not be positive, or predictive
of real - world results or
of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make
adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights
of third parties, or have unintended side effects,
adverse reactions or incidents
of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website
at www.sec.gov.
One must ask then how it is that if Protestant leaders in higher education generally made the right — or
at least virtually inevitable — decisions, what has gone wrong that the
outcome should be so
adverse to the apparent interests
of Protestant Christianity?
Explain that if they plan birth
at home there is a small increase in the risk
of an
adverse outcome for the baby.
Women who planned a home birth were
at reduced risk
of all obstetric interventions assessed and were
at similar or reduced risk
of adverse maternal
outcomes compared with women who planned to give birth in hospital accompanied by a midwife or physician.
For healthy nulliparous women with a low risk pregnancy, the risk
of an
adverse perinatal
outcome seems to be higher for planned births
at home, and the intrapartum transfer rate is high in all settings other than an obstetric unit
For nulliparous women, there is some evidence that planning birth
at home is associated with a higher risk
of an
adverse perinatal
outcome.
The strengths
of the study include the ability to compare
outcomes by the woman's planned place
of birth
at the start
of care in labour, the high participation
of midwifery units and trusts in England, the large sample size and statistical power to detect clinically important differences in
adverse perinatal
outcomes, the minimisation
of selection bias through achievement
of a high response rate and absence
of self selection bias due to non-consent, the ability to compare groups that were similar in terms
of identified clinical risk (according to current clinical guidelines) and to further increase the comparability
of the groups by conducting an additional analysis restricted to women with no complicating conditions identified
at the start
of care in labour, and the ability to control for several important potential confounders.
Labor induction has been increasing since the early 1990s, 1 and the rate is running
at about 20 % for pregnancies
at term.2, 3 Induction
of labor compared with spontaneous labor is associated with
adverse maternal
outcomes, including
at least a doubling in the caesarean delivery rate, 4,5 25 — 50 % increase in instrumental vaginal delivery rate, 3,5 higher postpartum hemorrhage rate, 5 and prolonged labor.5 Neonates born after induced labor are more likely to have low Apgar score and low umbilical cord blood pH. 5
Planned birth
at home in low risk women without complicating conditions
at the start
of care in labour was associated with significant cost savings and a significant decrease in
adverse perinatal
outcomes avoided.
There was, however, an increased incidence
of adverse perinatal
outcome associated with planned birth
at home in nulliparous low risk women, resulting in the probability
of it being the most cost effective option
at a cost effectiveness threshold
of # 20000 declining to 0.63.
We used multiple regression to estimate the differences in total cost between the settings for birth and to adjust for potential confounders, including maternal age, parity, ethnicity, understanding
of English, marital status, BMI, index
of multiple deprivation score, parity, and gestational age
at birth, which could each be associated with planned place
of birth and with
adverse outcomes.12 For the generalised linear model on costs, we selected a γ distribution and identity link function in preference to alternative distributional forms and link functions on the basis
of its low Akaike's information criterion (AIC) statistic.
In further analyses restricted to women without complicating conditions
at the start
of care in labour, the adjusted odds
of adverse perinatal
outcomes were higher for births planned
at home compared with those planned in obstetric units (adjusted odds ratio 1.59, 95 % confidence interval 1.01 to 2.52).
There was, however, an increased incidence
of adverse perinatal
outcomes associated with planned birth
at home in nulliparous low risk women, resulting in the probability
of it being the most cost effective option
at a threshold
of # 20000 declining to 0.63.
This review suggests that women who received midwife - led continuity models
of care were less likely to experience intervention and more likely to be satisfied with their care with
at least comparable
adverse outcomes for women or their infants than women who received other models
of care.
A comparison
of adverse neonatal
outcomes did not identify increased risk for babies born
at home as part
of the HBDP.
When we restricted the home - birth group to women who actually gave birth
at home, the rates
of adverse maternal and newborn
outcomes did not differ significantly from those among all planned home births.
Poor nutrition during these critical growth and developmental periods places infants and children
at risk
of impaired emotional and cognitive development and
adverse health
outcomes.
«Our research indicates that insertion
of cervical pessary
at around 22 weeks in both randomly selected women pregnant with twins and in patients with a short cervix
of less than 25 millimeters does not reduce the rate
of spontaneous early preterm birth, perinatal death,
adverse neonatal
outcome, or need for neonatal therapy.»
Both
adverse outcomes need to be studied further, according to Legro, who led a team that hosted the Chinese collaborators
at Penn State College
of Medicine for five weeks as the group wrote the protocol for the multi-center trial and participated in regular steering committee meetings overseeing the trial.
«After careful examination
of the burden
of disease among women aged 40 to 54 years, the guideline development group (GDG) concluded that the lesser, but not insignificant, burden
of disease for women aged 40 to 44 years and the higher cumulative risk
of adverse outcomes no longer warranted a direct recommendation to begin screening
at age 40 years.»
These behaviors predict more serious
adverse outcomes later in life, such as substance abuse, delinquency, and violence, explains study leader Anne Riley, PhD, professor in the Department
of Population, Family, and Reproductive Health
at the Johns Hopkins Bloomberg School
of Health.
«It's an exciting development, and we await the
outcome over the next year to see how well these cells integrate, and if there are any potential
adverse reactions,» says Mike Cheetham
of the Institute
of Ophthalmology
at University College London, one site where research is under way into a human embryonic stem - cell treatment for AMD.
«Mothers
of infants with complex congenital heart disease are exposed to increased stress, which has been associated with numerous
adverse outcomes,» said Barbara Medoff - Cooper, PhD, RN FAAN, principal investigator and nurse scientist in the Cardiac Center
at Children's Hospital
of Philadelphia and
at Penn Nursing.
In the article, Stamatina Iliodromiti from the University
of Glasgow, UK, and colleagues found birth weight less than 25th or greater than 85th centile to be associated with greater risk
of adverse outcomes compared with birth weight within these cutoffs, suggesting an expansion
of the definition
of «fetus
at risk» beyond the less than 10th or greater than 90th centile range that is commonly used to trigger surveillance
of fetal well - being and / or delivery.
The study, which randomly assigned 1873 HIV - negative pregnant women
at three sites in Malawi to receive either strategy, found that the risks
of adverse birth
outcomes,
at 29.9 and 28.8 percent, was similar in the two groups.
«Our findings have broad implications not only for malaria in pregnancy (125 million pregnancies
at risk each year), but also for other globally important causes
of adverse birth
outcomes such as preeclampsia,» says Dr. Kain, who is also Science Director, Tropical Disease Unit
at the Toronto General Hospital, UHN.
She suggests that inappropriately designed fitness programs and services put users
at increased risk
of injury and
adverse health
outcomes rather than providing them with the tools to build a healthy lifestyle.
«We have animal literature, which shows direct links between exposure and
adverse health
outcomes, the limited human studies, and the fact that 90 to 100 percent
of the population has measurable levels
of these compounds in their bodies,» said John Meeker, an assistant professor
of environmental health sciences
at the University
of Michigan School
of Public Health and a lead author.
This database will serve as a basis for a future larger study to identify susceptible subpopulations
at higher risk
of adverse pregnancy
outcomes.
«The fact that nearly half
of all highest - risk hospitalizations were followed by
at least one
adverse outcome — either suicide, unintentional injury death, suicide attempt or rehospitalization — argues strongly for developing expanded post-hospital preventive intervention services for these highest - risk soldiers.»
At least one
of these
adverse outcomes occurred in the year after discharge in 46.3 percent
of the highest - risk hospitalizations.
«The results
of this study were
of particular interest because more than half
of the pregnant women with migraine experienced some type
of adverse birth
outcome, suggesting that these pregnancies should be considered high risk,» said study author Matthew S. Robbins, M.D., director
of inpatient services
at Montefiore Headache Center, chief
of neurology
at Jack D. Weiler Hospital
of Montefiore, and associate professor
of clinical neurology
at Albert Einstein College
of Medicine.
«Overall, our results suggest a connection between opioid and heroin use and heroin - related
adverse outcomes at the population level, implying that frequent nonmedical users
of prescription opioids, regardless
of race or ethnicity, should be the focus
of public health efforts to prevent and mitigate the harms
of heroin use.»
«Together, these findings raise the possibility that hippocampal dysfunction in GWI is one
of the
adverse outcomes of persistently elevated oxidative stress and inflammation
at the systemic level,» he added.
There is evidence that rTMS is safe and not associated with any
adverse events, but given the variability in technique and
outcome reporting that prevented meta - analysis, the evidence for efficacy
of rTMS for seizure reduction is still lacking despite reasonable evidence that it is effective
at reducing epileptiform discharges.
The objectives
of the guidelines for the rational and responsible use
of antimicrobials are: - Optimal
outcome for male and female patients - Optimal use
of antibiotics (range, mode
of administration, dose, duration)- Minimizing side effects, such as
adverse effects, development
of resistance, nosocomial infections, C. difficile infections and costs The basics
of the guidelines are evidence, international and national guidelines, the epidemiology
of antimicrobial resistance
at the USZ and the ex-factory prices
of drugs.
Although it is often suggested that children with epilepsy who are benefiting from ketogenic dietary therapy continue this for
at least two years, duration
of treatment could be shorter in patients with infantile spasms who become seizure - free; one study reported no
adverse effect on seizure
outcomes and less risk
of growth disturbances when treatment was tapered down after 8 months (15).
According to new research published in the Journal
of Clinical Endocrinology and Metabolism, the current policy
of limiting thyroid tests to women
at high risk
of thyroid disease overlooks most cases
of thyroid disease during pregnancy, and undiagnosed, untreated thyroid disease in pregnancy carries a significant risk
of an
adverse outcome for both mother and baby.
The best chance
of getting a good underwriting
outcome will occur when lung cancer was diagnosed
at an early stage, like In Situ or Stage I. (Note, it is probable you will receive an
adverse rating if you apply too soon after completing cancer treatment.
Children who experience poverty, particularly during early life or for an extended period, are
at risk
of a host
of adverse health and developmental
outcomes through their life course.1 Poverty has a profound effect on specific circumstances, such as birth weight, infant mortality, language development, chronic illness, environmental exposure, nutrition, and injury.
Our findings add insight into the pathways linking early childhood adversity to poor adult wellbeing.29 Complementing past work that focused on physical health, 9 our findings provide information about links between ACEs and early childhood
outcomes at the intersection
of learning, behavior, and health.29 We found that ACEs experienced in early childhood were associated with poor foundational skills, such as language and literacy, that predispose individuals to low educational attainment and adult literacy, both
of which are related to poor health.23, 30 — 33 Attention problems, social problems, and aggression were also associated with ACEs and also have the potential to interfere with children's educational experience given known associations between self - regulatory behavior and academic achievement.34, 35 Consistent with the original ACE study and subsequent research, we found that exposure to more ACEs was associated with more
adverse outcomes, suggesting a dose — response association.3 — 8 In fact, experiencing ≥ 3 ACEs was associated with below - average performance or problems in every
outcome examined.
Bright Futures, the AAP health promotion initiative, provides resources for pediatricians to detect both ACEs and
adverse developmental
outcomes.36 Programs like Reach Out and Read, in which pediatricians distribute books and model reading, simultaneously promote emergent literacy and parent — child relationships through shared reading.37, 38 However, ACEs can not be addressed in isolation and require collaborative efforts with partners in the education, home visitation, and other social service sectors in synergistic efforts to strengthen families.29 In this way, programs like Help Me Grow39 that create streamlined access to early childhood services for
at - risk children can play a critical role in building an integrated system that connects families to needed resources to enhance the development
of vulnerable children.
Cannabis use can be a significant contributor to poor mental health, particularly when it begins
at a young age.4, 5 The
adverse mental health effects
of cannabis use in the general population are increasingly recognised, including anxiety, depression, 6 — 8 psychotic disorders, 4, 9 — 12 dependence6, 7, 13 withdrawal14, 15 and cognitive impairment.16, 17 Starting to use cannabis before age 15 is associated with an increased likelihood
of developing later psychotic disorders, increased risk
of dependence, other drug use, and poor educational and psychosocial
outcomes.5
Relative to children with no ACEs, children who experienced ACEs had increased odds
of having below - average academic skills including poor literacy skills, as well as attention problems, social problems, and aggression, placing them
at significant risk for poor school achievement, which is associated with poor health.23 Our study adds to the growing literature on
adverse outcomes associated with ACEs3 — 9,24 — 28 by pointing to ACEs during early childhood as a risk factor for child academic and behavioral problems that have implications for education and health trajectories, as well as achievement gaps and health disparities.
Felitti and colleagues1 first described ACEs and defined it as exposure to psychological, physical or sexual abuse, and household dysfunction including substance abuse (problem drinking / alcoholic and / or street drugs), mental illness, a mother treated violently and criminal behaviour in the household.1 Along with the initial ACE study, other studies have characterised ACEs as neglect, parental separation, loss
of family members or friends, long - term financial adversity and witness to violence.2 3 From the original cohort
of 9508 American adults, more than half
of respondents (52 %) experienced
at least one
adverse childhood event.1 Since the original cohort, ACE exposures have been investigated globally revealing comparable prevalence to the original cohort.4 5 More recently in 2014, a survey
of 4000 American children found that 60.8 %
of children had
at least one form
of direct experience
of violence, crime or abuse.6 The ACE study precipitated interest in the health conditions
of adults maltreated as children as it revealed links to chronic diseases such as obesity, autoimmune diseases, heart, lung and liver diseases, and cancer in adulthood.1 Since then, further evidence has revealed relationships between ACEs and physical and mental health
outcomes, such as increased risk
of substance abuse, suicide and premature mortality.4 7
Approximately 37 %
of all children live in poverty for some period during their childhood.16 Children who are born into poverty and live persistently in poor conditions are
at greatest risk
of adverse outcomes.
Recent examinations into the
outcomes of childhood trauma have resulted in findings that demonstrate the notion that extreme childhood adversity is not only linked to undesirable juvenile and adult behaviors, but that there is also an intergenerational risk factor associated with
adverse experiences
at a young age (e.g., Bifulco et al., 2002; Chartier, Walker, & Naimark, 2010; Felitti et al., 1998; Gregorowski & Seedat, 2013; Mersky, Topitzes, & Reynolds, 2013; Sameroff, 2000).
Maternal glucose
at 28 weeks
of gestation is not associated with obesity in 2 - year - old offspring: the Belfast Hyperglycemia and
Adverse Pregnancy
Outcome (HAPO) family study
Where both parents are depressed, the child is
at far greater disadvantage and poorer
outcomes have been observed in children up to the age
of 7.32 Heightened parental anxiety may result in
adverse outcomes for the child, who is also put
at increased risk
of anxiety.33 Given that children born preterm are already
at some disadvantage in comparison to their peers born
at term, an increase in the prevalence
of PD among this group
of parents could compound the negative impact
of an early delivery on child
outcomes.